Expression of Insulin-like Growth Factors in a Mouse Model of Salicylate Ototoxicity

Objectives Insulin-like growth factors (IGFs) are known to be neurotrophic factors, and they efficiently signal to cells to grow, differentiate and survive. The purpose of study was to identify the expressions of IGFs in mice with salicylate ototoxicity, which is a typical reversible hearing loss model. Methods The mice were given intraperitoneal injections of salicylate (400 mg/kg) and about a 30 dB threshold shift was achieved at 3 hours. The expressions of IGF-1 and 2 were confirmed by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. Localization of IGFs was confirmed using confocal immunofluorescence imaging. For in-vitro study on the HEI-OC1 auditory cells, the cell viability was calculated and the apoptotic features of the nuclei were observed with Hoechst staining. Results The expressions of the IGFs mRNA and protein were significantly increased in the salicylate ototoxicity groups compared with that of the normal control group. Salicylate induced apoptosis and decreased viability of the HEI-OC1 auditory cells in a time- and dose-dependent manner. The expressions of IGFs were localized in the stria vascularis, and these IGFs play a protective role in the in-vivo condition of salicylate ototoxicity. Conclusion IGFs were highly expressed in the mice with salicylate ototoxicity, and this expression was mainly focused in the stria vascularis in the salicylate intoxicated mice. The systemic action of IGFs, which were expressed in the vascular-rich stria vascularis, can act as a major protective mechanism in a mouse model of salicylate ototoxicity.

[1]  J. Chung,et al.  Apoptotic Pattern of Cochlear Outer Hair Cells and Frequency-specific Hearing Threshold Shift in Noise-exposed BALB/c Mice , 2008, Clinical and experimental otorhinolaryngology.

[2]  S. Kar,et al.  Effect of kainic acid treatment on insulin-like growth factor-2 receptors in the IGF2-deficient adult mouse brain , 2007, Brain Research.

[3]  H. Jung,et al.  Differential gene expression profiles in salicylate ototoxicity of the mouse. , 2007, Acta oto-laryngologica.

[4]  P. Cohen Overview of the IGF-I System , 2006, Hormone Research in Paediatrics.

[5]  G. Camarero,et al.  Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear , 2004, Hearing Research.

[6]  I. Gorospe,et al.  Programmed cell death in the development of the vertebrate inner ear , 2004, Apoptosis.

[7]  D. Lim,et al.  A Cochlear Cell Line as an in vitro System for Drug Ototoxicity Screening , 2003, Audiology and Neurotology.

[8]  Eva L Feldman,et al.  Control of cell survival by IGF signaling pathways. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[9]  C. Avendaño,et al.  Cochlear abnormalities in insulin-like growth factor-1 mouse mutants , 2002, Hearing Research.

[10]  Gustave Moonen,et al.  Identification of factors that maintain mammalian outer hair cells in adult organ of Corti explants , 2002, Hearing Research.

[11]  P. Ye,et al.  Myelination Is Altered in Insulin-Like Growth Factor-I Null Mutant Mice , 2002, The Journal of Neuroscience.

[12]  A. Hassan,et al.  Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. , 2001, Development.

[13]  C. Avendaño,et al.  Delayed Inner Ear Maturation and Neuronal Loss in PostnatalIgf-1-Deficient Mice , 2001, The Journal of Neuroscience.

[14]  H. Okano,et al.  Expression of mouse igf2 mRNA‐binding protein 3 and its implications for the developing central nervous system , 2001, Journal of neuroscience research.

[15]  Y. Cazals Auditory sensori-neural alterations induced by salicylate , 2000, Progress in Neurobiology.

[16]  J. Terzis,et al.  End‐to‐Side Neurorrhaphy Evaluation of Axonal Response and Upregulation of IGF‐I and IGF‐II in a Non‐Injury Model , 1999, Journal of reconstructive microsurgery.

[17]  H. Staecker,et al.  Factors controlling hair-cell regeneration/repair in the inner ear , 1998, Current Opinion in Neurobiology.

[18]  Ian N. M. Day,et al.  Molecules in focus Insulin-like growth factor II (IGF-II) , 1998 .

[19]  I. Day,et al.  Insulin-like growth factor II (IGF-II). , 1998, The international journal of biochemistry & cell biology.

[20]  T. Lauterio The effects of IGF-I and IGF-II on cell growth and differentiation in the central nervous system. , 1992, Advances in experimental medicine and biology.

[21]  P. Schofield,et al.  Insulin-like growth factors and the multiplication of Tera-2, a human teratoma-derived cell line. , 1988, Journal of cell science.